10 hours ago
1
Novavax (NASDAQ:NVAX) was on track to end its seventh consecutive session in the red territory after shares of the company declined 1.73% to $6.54 on Friday afternoon.
The vaccine maker lost close to 13% in the previous six sessions. The fall followed
English (US) ·